Evidence map›Paper›PMID 33804024›Full record

ReviewCancers2021

Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN).

Lorenzo Fornaro, Andrea Spallanzani, Ferdinando de Vita, Domenico D'Ugo, Alfredo Falcone, Laura Lorenzon, Giuseppe Tirino, Stefano Cascinu, GAIN (GAstric Cancer Italian Network)

Abstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lorenzo FornaroDepartment of Translational Medicine, Division of Medical Oncology, AOU Pisana, 56126 Pisa, Italy.ORCID 0000-0002-0187-5904
Andrea SpallanzaniDepartment of Oncology and Hematology, University Hospital of Modena, 41125 Modena, Italy.ORCID 0000-0001-6955-7139
Ferdinando de VitaDepartment of Precision Medicine, Division of Medical Oncology, School of Medicine, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.
Domenico D'UgoGeneral Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, 00168 Rome, Italy.ORCID 0000-0001-6657-6318
Alfredo FalconeDepartment of Translational Medicine, Division of Medical Oncology, University of Pisa, 56126 Pisa, Italy.
Laura LorenzonGeneral Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, 00168 Rome, Italy.ORCID 0000-0001-6736-0383
Giuseppe TirinoDepartment of Precision Medicine, Division of Medical Oncology, School of Medicine, University of Campania 'Luigi Vanvitelli', 81100 Caserta, Italy.ORCID 0000-0003-3611-5275
Stefano CascinuMedical Oncology, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
GAIN (GAstric Cancer Italian Network)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManagement of gastric and gastroesophageal junction (GEJ) adenocarcinoma remains challenging, because of the heterogeneity in tumor biology within the upper gastrointestinal tract. Daily clinical practice is full of grey areas regarding the complexity of diagnostic, staging, and therapeutic procedures. The aim of this paper is to provide a guide for clinicians facing challenging situations in routine practice, taking a multidisciplinary consensus approach based on available literature.

methodsThe GAIN (GAstric cancer Italian Network) group was established with the aims of reviewing literature evidence, discussing key issues in prevention, diagnosis, and management of gastric and GEJ adenocarcinoma, and offering a summary of statements. A Delphi consensus method was used to obtain opinions from the expert panel of specialists.

resultsForty-nine clinical questions were identified in six areas of interest: role of multidisciplinary team; risk factors; diagnosis; management of early gastric cancer and multimodal approach to localized gastric cancer; treatment of elderly patients with locally advanced resectable disease; and treatment of locally advanced and metastatic cancer.

conclusionsThe statements presented may guide clinicians in practical management of this disease.

Indexed as

diagnosisgastric cancerGEJ adenocarcinomarecommendationstreatment

Identifiers

PMID33804024
PMCPMC8001719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.